Sun Pharmaceutical completes merger with Taro Pharmaceutical to enhance market position
Sun Pharmaceutical Industries Limited has announced the completion of its strategic merger with Taro Pharmaceutical Industries Ltd. (NYSE: TARO), marking a significant consolidation in the pharmaceutical industry. With this merger, Taro has transitioned into a privately held company, wholly owned by Sun Pharma. Prior to this merger, Sun Pharma had been the majority shareholder of […]